Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy
Nature Medicine2007Vol. 14(1), pp. 37–44
Citations Over TimeTop 10% of 2007 papers
Jian Qiao, Timothy Kottke, Candice Willmon, Feorillo Galivo, Phonphimon Wongthida, Rosa María Díaz, Jill Thompson, Pamela K. Ryno, Glen N. Barber, John Chester, Peter J. Selby, Kevin J. Harrington, Alan Melcher, Richard G. Vile
Related Papers
- → Oncolytic Virotherapy as Promising Immunotherapy Against Cancer: Mechanisms of Resistance to Oncolytic Viruses(2021)31 cited
- → Enhancing oncolytic virotherapy: Observations from a Voronoi Cell-Based model(2019)26 cited
- → Treatment of Metastatic Neuroblastoma with Mesenchymal Stem Cell‐Based Oncolytic Virotherapy(2013)
- → Mesenchymal stem cells as carrier cells to enable effective intratumoral delivery of oncolytic virus for oncolytic virotherapy: a systematic review(2022)
- → Oncolytic Virotherapy: An Advanced Microbial Approach for the Management of Cancer(2023)